Dr Emily Holmes

Research Fellow in Pharmacoeconomics

Contact info

Ardudwy

Normal Site

Bangor University

Holyhead Road

Bangor

Wales

LL57 2PZ

 

e-mail: e.holmes@bangor.ac.uk

Tel: +44 (0)1248 382709

Twitter: @EAFHolmes

Web: http://cheme.bangor.ac.uk

 

Overview

Emily’s research interests and expertise include preference elicitation, medication adherence, and pharmacoeconomic evaluation.  She is Principal Investigator of studies evaluating: treatment preferences, medicines management in prison, antimicrobial prescribing, and attitudes towards epilepsy.  She is co-investigator on a study of emergency care following seizures (Collaborate), and she supports several projects in CHEME aligned to her interests of medication adherence (SuMMiT-D), preferences for medicines administration/outcomes (CARiAD), and neurology (EN-PNS, SAFE). 

 

Emily graduated in Economics at the University of Liverpool and started her career at the University of Manchester, before taking her position at Bangor University.  She completed her doctoral research in behavioural economics and health psychology of medication adherence.    Emily has over 40 published papers and conference proceedings, she edits health technology assessment reports for the All Wales Therapeutics and Toxicology Centre (AWTTC), and is a member of the Epilepsy Action Scientific Awards Panel and the Bangor University Athena SWAN task group.

Contact Info

Ardudwy

Normal Site

Bangor University

Holyhead Road

Bangor

Wales

LL57 2PZ

 

e-mail: e.holmes@bangor.ac.uk

Tel: +44 (0)1248 382709

Twitter: @EAFHolmes

Web: http://cheme.bangor.ac.uk

 

Research

Principal Investigator:

Patient centred benefit-risk assessment of treatment for colorectal liver metastases in North West England and North Wales (NWCR).

Modelling the health economic outcomes of ‘medicines management of sedating medications’ at HMP Berwyn. A feasibility study (BCUHB).

Developing a protocol and conducting an appropriately powered random-stratified sample of the UK population, to measure changing public attitudes to epilepsy and people with epilepsy (Epilepsy Action).

Cost effectiveness analysis of the use of C reactive protein point of care tests in primary care; a model based on the North Wales pilot project (BCUHB).

Co-investigator:

Developing patient-centred, feasible alternative care for emergency department users with epilepsy. A model for service design (NIHR).

Appointed Research Fellow for Health Economics:

A randomised patient-assessor blinded controlled trial of External non-invasive peripheral nerve stimulation for chronic neuropathic pain following peripheral nerve injury (EN-PENS).

A follow-on study to develop and pilot ‘Seizure first Aid training For Epilepsy’ (SAFE) for people with epilepsy who attend emergency departments, and their family and friends.

Supporting people with type 2 diabetes in effective use of their medicine through a system comprising mobile health technology integrate with clinical care (SUMMiT-D).

CARer-ADministration of as-needed sub-cutaneous medication for breakthrough symptoms in homebased dying patients: a UK study (CARiAD).

Teaching and Supervision

PhD Supervision:

Nafees Din.  Androgens - CHOice of Intermittent vs Continual– Prostate Cancer (A CHOICe-PC), funded by Tenovus Cancer Care.   PhD Health Sciences, Bangor University.

Short Course Teaching:

Pharmacoeconomics short course, Bangor University. 

Online Course Contributor :

European Society for Patient Adherence, Compliance and Persistence (ESPACOMP) educational course.

Other

Member of Bangor University Athena SWAN Task Group

Member of Epilepsy Action Scientific Awards Panel

NIHR and HCRW Reviewer

Personal

Epilepsy Action Local Services Volunteer

Education / academic qualifications

  • 2017 - PhD , Understanding medication adherence: application of health psychology & behavioural economic theories , Bangor University
  • 2005 - MSc , Health Economics and Health Policy
  • 2001 - BA , Economics
View graph of relations